BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Kline & Specter, P.C. Release: Three Bextra Lawsuits Filed


10/19/2005 5:13:15 PM

NEW YORK, April 11 /PRNewswire/ -- Lawsuits have been filed against the maker of Bextra on behalf of three people injured by the recently suspended prescription drug. Two of the plaintiffs suffered heart attacks and one sustained a stroke after taking the painkiller manufactured by Pfizer Inc.

The suits were filed in the Supreme Court of the State of New York on Friday, one day after New York-based Pfizer removed Bextra from the market at the urging of the U.S. Food and Drug Administration.

The plaintiffs are all represented by Thomas R. Kline of the Philadelphia law firm Kline & Specter, P.C., who on Friday was also named to the Plaintiffs Steering Committee in the federal litigation over Vioxx, like Bextra a COX-2 inhibitor drug (made by Merck & Co.) that has been removed from the market because of links to heart attack and stroke.

The Bextra lawsuits claim, among other things, that Pfizer failed to adequately and properly test Bextra and failed to warn doctors, patients and others about its potential risks. Studies showed that patients who used Bextra were more likely to suffer heart attacks and strokes.

The plaintiffs in the Bextra suit are:

- Luis G. Flores, 33, of Texas, who suffered a heart attack on Aug. 5, 2004 and, as a result, was forced to undergo two stent implantation surgeries.

- Jimmy Kitchen, 67, of Arkansas, who suffered a heart attack on June 12, 2002.

- Theodis Maddox, Jr., 48, of Arkansas, who suffered a stroke and temporary paralysis and weakness on his right side.

Kline & Specter (http://www.klinespecter.com/), with offices in Philadelphia, New Jersey and New York, represents people across the nation in pharmaceutical litigation and a wide range of catastrophic injury, mass tort, class action and complex litigation.

Kline & Specter, P.C.

CONTACT: Tom Kline of Kline & Specter, +1-215-772-1000 or+1-215-432-9065 (cell) or (preferred) tom.kline@klinespecter.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES